Dr Elizabeth Robertson: key facts
- Kind of voice
- Sector leader
- Role
- director of research and clinical at Diabetes UK
- Quoted on
- Diabetes, Children's health, Hospital discharge / bed-blocking
- Tracked press citations
- 7
- Most recently quoted
- 30 Sept 2026
- First quoted
- 27 Aug 2026
“The Type 1 Diabetes Grand Challenge set out to fund bold, ambitious research with the potential to fundamentally shift progress toward new treatments and, ultimately, a cure for type 1 diabetes. This study delivers on that vision by challenging the foundations of previous understanding about the development of type 1 diabetes in early childhood.”
What Dr Elizabeth Robertson has said
“Today's landmark approval of teplizumab marks the start of a new age of type 1 diabetes treatment. For the first time in 100 years, we are moving beyond insulin, with a medicine that targets the root cause of the condition.”
Director of Research and Clinical at Diabetes UK · Diabetes · 30 Sept 2026 · Teplizumab, the first treatment to slow type 1 diabetes, approved for use on the NHS ↗
“The ELSA study, co-funded by Diabetes UK, is generating the evidence needed to make type 1 diabetes screening a reality for every family in the UK.”
Director of Research and Clinical at Diabetes UK · Diabetes · 30 Sept 2026 · National childhood type 1 screening is effective and could prevent thousands of emergency diagnoses ↗
“This is an extraordinary moment for celebration in the type 1 diabetes community and represents a shift towards a future where type 1 diabetes can be prevented altogether.”
director of research and clinical at Diabetes UK · Children's health · 10 Sept 2026 · Immunotherapy to delay type 1 diabetes onset approved by NICE ↗
“For too many families, a child's type 1 diabetes diagnosis still comes as a frightening emergency. But that doesn't have to be the case. Thanks to scientific breakthroughs, we now have the tools to identify children in the very earliest stages of type 1 diabetes – giving families precious time to prepare, avoid emergency hospital admissions, and access treatments that can delay the need for insulin for years.”
Director of Research and Clinical at Diabetes UK · Diabetes · 10 Sept 2026 · National childhood type 1 diabetes screening is effective and could prevent thousands of emergency diagnoses ↗
“Today's landmark licensing of teplizumab in the UK marks a turning point in the treatment of type 1 diabetes. For the first time, we have a medicine that targets the root cause of the condition, offering three precious extra years free from the relentless demands of managing type 1 diabetes.”
director of research and clinical at Diabetes UK · Diabetes · 8 Sept 2026 · Breakthrough drug slows onset of type 1 diabetes ↗
“Today's landmark approval of teplizumab marks the start of a new age of type 1 diabetes treatment. For the first time in 100 years, we are moving beyond insulin, with a medicine that targets the root cause of the condition.”
director of research at the charity Diabetes UK · Hospital discharge / bed-blocking · 27 Aug 2026 · Drug that delays onset of type 1 diabetes approved in England and Wales ↗
Where Dr Elizabeth Robertson has been quoted
- Landmark research uncovers why type 1 diabetes is more aggressive in young childrennews.exeter.ac.uk · 30 Sept 2026
- Teplizumab, the first treatment to slow type 1 diabetes, approved for use on the NHSdiabetes.org.uk · 30 Sept 2026
- National childhood type 1 screening is effective and could prevent thousands of emergency diagnosesdiabetes.org.uk · 30 Sept 2026
- Immunotherapy to delay type 1 diabetes onset approved by NICEpulsetoday.co.uk · 10 Sept 2026
- National childhood type 1 diabetes screening is effective and could prevent thousands of emergency diagnosesdiabetestimes.co.uk · 10 Sept 2026
- Breakthrough drug slows onset of type 1 diabetesaol.com · 8 Sept 2026
- Drug that delays onset of type 1 diabetes approved in England and Walestheguardian.com · 27 Aug 2026
Related media coverage
Recent UK press coverage of their topics — not necessarily citing them directly.
Chief executives, directors and spokespeople of trade bodies, representative associations and charities speaking for the sector. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.